Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/23402
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKurnar, A K Hernanth-
dc.contributor.authorGurumurthy, Prema-
dc.date.accessioned2013-11-12T09:48:02Z-
dc.date.available2013-11-12T09:48:02Z-
dc.date.issued2004-03-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/23402-
dc.description323-325en_US
dc.description.abstractDisposition of uric acid upon administration of ofloxacin (O) alone and in combination with other anti-tuberculosis drugs, rifampicin (R), isoniazid (H) and pyrazinamide (Z) was studied. Twelve male healthy volunteers were investigated on four different occasions with the four drugs alone or in combinations. A partially balanced incomplete block design was adopted and the subjects were randomly allocated to each group. Uric acid concentration in urine samples excreted over 0-8 hr, were determined after coding the samples. There was significant decrease in the group receiving Z when compared to other groups. Though there was a decrease in uric acid excretion in the group receiving O, it was not statistically significant. Rifampicin and H seem to increase the uric acid excretion. The incidence of arthralgia was mainly due to Z and not due to either O or other drugs in the treatment of pulmonary tuberculosis.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.42(03) [March 2004]en_US
dc.subjectAnti-tuberculosis drugsen_US
dc.subjectOfloxacinen_US
dc.subjectUric acid dispositionen_US
dc.titleDisposition of uric acid upon administration of ofloxacin alone and in combination with other anti-tuberculosis drugsen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.42(03) [March 2004]

Files in This Item:
File Description SizeFormat 
IJEB 42(3) 323-325.pdf844.96 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.